Atara Biotherapeutics, Inc. (LON:0HIY)
7.08
-0.52 (-6.88%)
At close: Feb 21, 2025
Atara Biotherapeutics Employees
Atara Biotherapeutics had 225 employees as of December 31, 2023. The number of employees decreased by 109 or -32.63% compared to the previous year.
Employees
225
Change (1Y)
-109
Growth (1Y)
-32.63%
Revenue / Employee
471.31K GBP
Profits / Employee
-624.85K GBP
Market Cap
32.39M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Genus | 3,500 |
Atara Biotherapeutics News
- 15 days ago - Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 16 days ago - The Schall Law Firm Invites Shareholders With Losses In Atara Biotherapeutics, Inc. To Join A Securities Fraud Investigation - Accesswire
- 16 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA - Accesswire
- 16 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Atara Biotherapeutics, Inc. (ATRA) And Encourages Shareholders to Connect - Accesswire
- 17 days ago - Atara Biotherapeutics, Inc. Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm - Accesswire
- 17 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Atara Biotherapeutics, Inc. (ATRA) And Encourages Investors to Connect - Accesswire
- 18 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Atara Biotherapeutics, Inc. (ATRA) Stockholders to Inquire about Securities Investigation - Accesswire
- 19 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Atara Biotherapeutics, Inc. (ATRA) and Encourages Investors to Learn More About the Investigation - Accesswire